First database of genomic variants for Vietnamese population announced
Vingroup Big Data Institute VinBigData announced on December 16 that it has completed the project on Database of Genomic Variants for Vietnamese Population.
Hanoi (VNA) – Vingroup Big DataInstitute VinBigData announced on December 16 that it has completed the project on Databaseof Genomic Variants for Vietnamese Population.
With over 1,000 genomes sequenced and over 40million variants discovered, the research will lay a foundation for biomedicaland precision medicine development, contributing to giving early treatment to eachVietnamese individual in the future.
The first database of its kind also has enoughannotations about biological functions and pathological risks.
Prof. Ta Thanh Van, Chairman of the Council ofHanoi Medical University, said the database will provide an invaluablereference to improve the efficiency of diagnosis and treatment in the country.
Launched in December 2018, theproject drew the participation of over 40 scientists from leading universitiesand units worldwide as well as hundreds of experts and volunteers at home andabroad.
During three years, theysequenced genomes of over 1,000 unrelated adults aged 35-55 and discovered morethan 40 million genetic variants, nearly 2 million of them are representativeof the Vietnamese population. The process was made at a lab meeting ISO 15189standards at Vinmec International General Hospital, using advanced technologiesby Google, Illumina and NVIDIA.
Part of the database is nowavailable at //genome.vinbigdata.org.Several hi-speed analysis tools are also offered on trial there.
The pionee🐬ring projectcosts over 4.5 million USD, the largest scale in Vietnam so far./.
The Vinmec Research Institute of Stem Cell and Gene Technology has revealed initial results of the Vietnamese genome decoding project after more than two years of research.
The prestigious Human Mutation Magazine has recently published a research on the Vietnamese genome. The research is the largest database ever of Vietnamese genome.
Microbiome, also referred to as the Second Genome, is a field that can be widely used for research on new drug development and treatment of incurable diseases as it can help analyze the relationship between the principle of the generation of beneficial bacteria and harmful bacteria and diseases.
Genetica, a genetic engineering company with patented technology from the US, has inked a cooperation deal with the Vietnam National Innovation Centre (NIC) to develop a genome sequencing centre, the largest of its kind in Southeast Asia.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
At the lab (Photo: VNA) 
